Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation

PURPOSE: To undercover the underlying mechanisms of luteolin against atopic dermatitis (AD), clinically characterized by recurrent eczematous lesions and intense itching, based on network pharmacology, molecular docking and in vivo experimental validation. METHODS: TCMSP, STITCH and SwissTargetPredi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Liu, Gao, Jiefang, Li, Xiaolei, Cao, Xiaoqin, Zhou, Benhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748122/
https://www.ncbi.nlm.nih.gov/pubmed/36530790
http://dx.doi.org/10.2147/DDDT.S387893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748122/
https://www.ncbi.nlm.nih.gov/pubmed/36530790
http://dx.doi.org/10.2147/DDDT.S387893

Ejemplares similares